THE VALUE OF BASAL EXPRESSION LEVEL OF HEMOXYGENASE-1 FOR SENSITIVITY OF HUMAN MELANOMA CELLS TO OXIDATIVE STRESS IN VITRO
Open Access
- 12 October 2020
- journal article
- research article
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 19 (3) , 38-45
Abstract
Introduction. The molecular basis of radio- and photodynamic therapy (PDT), the mechanism of action of a number of antitumor chemotherapy drugs is oxidative stress (OS). The enzyme hemoxygenase-I (НO-1), a molecular marker of OS, is a key participant in the system of protection and adaptation of tumor cells under stress.Objective. To find out whether the sensitivity of human melanoma tumor cells to OS depends on the basal and modulator-induced levels of НO-1 expressionMaterial and methods. Human melanoma cell lines were used in the study. The expression of mRNA НO-1 in cells was studied by real-time RT-PCR, the reactive oxygen species content in cells – by flow cytometry and the cytotoxicity of drugs – by MTT assay.Results. According to our data, human melanoma cells have different basal levels of HO-1 transcription: high (3.0–3.5 o. u.) in lines MelIL, MelP, medium (1.5 o. u.) in lines MeWo, MelZ, MelIbr and low (0.5 o. e.) – MelMe, A375).There is no direct correlation between the level of basal cell expression of HO-1 and their sensitivity to the OS inducer – Н2О2. The hemin-induced increase in HO-1 expression in cells is accompanied by doubled resistance to Н2О2. It was found that HO-1 repression in the presence of apigenin was registered in melanoma cells with different basal levels, but sensitization to Н2О2 (2–4 times) was observed only for cells with medium (MeWo) and low (A375) levels of basal HO-1 expression. It was found that the decrease in basal expression of HO-1 induced by apigenin is accompanied by an increase in the reactive oxygen species content in cells.Conclusions. The results of our research allow us to recommend natural flavon apigenin, a modulator of HO-1 expression, for inclusion in the chemotherapy and PDT regimens to increase the effectiveness of human melanoma treatment.Keywords
This publication has 18 references indexed in Scilit:
- Heme Oxygenase-1/Ferritin in Protection of Leukemia Cells from Oxidative Stress Induced by Catalytic System “Teraphtal + Ascorbic Acid”Clinical oncohematology, 2019
- Ultraviolet radiation-mediated development of cutaneous melanoma: An updateJournal of Photochemistry and Photobiology B: Biology, 2018
- A novel heme oxygenase-1 splice variant, 14kDa HO-1, promotes cell proliferation and increases relative telomere lengthBiochemical and Biophysical Research Communications, 2018
- The non-canonical functions of the heme oxygenasesOncotarget, 2016
- Epidemiology of invasive cutaneous melanomaAnnals of Oncology, 2009
- Reactive oxygen species in melanoma and its therapeutic implicationsMelanoma Research, 2007
- Non-heme Induction of Heme Oxygenase-1 Does Not Alter Cellular Iron MetabolismJournal of Biological Chemistry, 2007
- Hydrogen peroxide generated extracellularly by receptor–ligand interaction facilitates cell signalingProceedings of the National Academy of Sciences, 2005
- Regulation of ferritin genes and proteinBlood, 2002
- Role of reactive oxygen species in apoptosis: implications for cancer therapyThe International Journal of Biochemistry & Cell Biology, 2000